Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Manufacturing

AbbVie opts for North Carolina to house $1.4bn manufacturing site

 April 23, 2026

Pharmaceutical Technology

This Durham-based facility will be AbbVie’s first manufacturing site in the state, and will become a centre of excellence for SVP production.

ManufacturingRead full story

Post navigation

MSD teams up with Google Cloud on agentic AI transformation →
← Sanofi receives FDA approval for Tzield in paediatric diabetes

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com